U.S. Biotech Stock News

Immunocore Holdings plc recently reported fourth-quarter 2025 revenue of US$104.48 million and a quarterly net loss of US$30.06 million, alongside full-year 2025 revenue of US$400.02 million and a full-year net loss of US$35.51 million. The company paired this earnings update with a packed schedule of March 2026 healthcare conference appearances in Boston and Miami, signaling active engagement with investors and the broader biotech community. We’ll now examine how the full-year revenue...

Papa John's International, Inc. recently reported weaker fourth-quarter and full-year 2025 results, with revenue slipping to US$498.18 million in Q4 and full-year net income falling to US$30.53 million, and guided for global system-wide restaurant sales in 2026 to be flat to down low single-digits. The company also plans to close about 200 North American stores and pursue cost optimization programs targeting at least US$25 million in savings by 2027 and US$60 million in supply chain savings...

RBC Bearings Incorporated recently presented at the 47th Annual Raymond James Institutional Investor Conference in Orlando and released a mixed quarter, with year-on-year revenue growth supported by its Aerospace & Defense operations and steady Industrial performance. Management highlighted a growing aerospace and defense backlog, a focus on profitable growth, and expanding production capacity, underlining efforts to strengthen long-term cash generation and contract visibility. Next, we’ll...

Alpine Income Property Trust, Inc. recently originated a US$32.0 million first mortgage loan, funding US$8.6 million at close, to back the development of an 11‑acre, 101,000‑square‑foot retail center with investment grade tenants and three outparcels in the Covington Town Center master plan near Atlanta. The high‑coupon, 24‑month loan tied to a Target‑anchored project adjacent to an existing Publix highlights Alpine’s growing use of higher‑yield structured financing alongside its net lease...

Westlake Corporation has reported its fourth-quarter 2025 results, with sales of US$2,533 million and a net loss of US$544 million, compared with a small profit a year earlier. For 2025 as a whole, Westlake’s sales declined to US$11.17 billion and the company moved from a net income of US$602 million to a net loss of US$1.51 billion, sharply reversing its prior profitability. We’ll now examine how this swing from profit to a sizeable loss may affect Westlake’s earlier investment narrative...

Phase 2 NDV-01 data and what it could mean for Relmada Therapeutics (RLMD) Relmada Therapeutics (RLMD) has drawn fresh attention after reporting 12 month interim Phase 2 data for NDV-01 in high risk non muscle invasive bladder cancer, showing strong complete response rates and a favorable safety profile. See our latest analysis for Relmada Therapeutics. The NDV-01 update and recent Leerink healthcare conference appearance came alongside a sharp shift in sentiment, with Relmada Therapeutics’ 1...

Bausch + Lomb (BLCO) is drawing fresh attention after announcing an upcoming R&D webinar focused on its glaucoma pipeline, including drug candidate BL1107 and the ELIOS minimally invasive glaucoma surgery platform. See our latest analysis for Bausch + Lomb. The upcoming glaucoma webinar follows a mixed stretch for the stock, with a 1-day share price return of 0.94% and a 7-day share price decline of 6.46%. This sits alongside a 1-year total shareholder return of 8.30% and a 3-year total...

Ichor Holdings recently presented at the Stifel 2026 NYC Technology One-on-One Conference at The Conrad New York Downtown, offering investors detailed updates on its semiconductor equipment business. A sharp sector-wide reset in semiconductor sentiment, driven by fresh regulatory and geopolitical concerns, has put additional focus on how resilient Ichor’s fundamentals and long-term positioning really are. We’ll now examine how this sector-wide regulatory uncertainty, rather than...

Earnings, guidance and new buyback set the backdrop DoubleVerify Holdings (DV) is in focus after reporting full year 2025 results, issuing 2026 revenue guidance and unveiling a new US$300 million share repurchase program on February 26. Sales for 2025 came in at US$748.29 million versus US$656.85 million a year earlier, while net income was US$50.65 million compared with US$56.23 million. Basic earnings per share from continuing operations were US$0.31, with diluted earnings per share at...

Axsome Therapeutics recently dosed the first patient in its CLARITY Phase 3 trial of solriamfetol for major depressive disorder with excessive daytime sleepiness and has also been granted FDA Priority Review for AXS-05 in Alzheimer’s disease agitation, while management engaged investors at several March healthcare conferences. Together, the new late-stage solriamfetol study and the upcoming AXS-05 regulatory decision highlight how Axsome is steadily broadening its central nervous system...

Universal Corporation recently reported quarterly results that fell short of expectations, with earnings per share and net income dropping sharply amid an oversupplied tobacco market and weaker ingredients performance. The company’s move to upsize its credit facility and appoint a new CFO with ingredients experience highlights both liquidity pressures and a renewed push to diversify beyond core tobacco. Now we will examine how the earnings miss and ingredients segment setback could reshape...

At its extraordinary general meeting held on 10 March 2026, GDS Holdings Limited approved amendments to its Articles of Association that increased the voting power of Class B ordinary shares held by CEO William Wei Huang from 20 votes per share to 50 votes per share. This move materially concentrates control in the hands of the founder-CEO, reshaping the company’s governance balance and long-term decision‑making framework. We’ll now examine how this sharp increase in the CEO’s voting control...

Conference appearance and recent market signals Select Water Solutions (WTTR) recently presented at the 47th Annual Raymond James Institutional Investor Conference in Orlando, giving management a platform to outline its capital plans and segment priorities to institutional investors. This appearance follows solid fiscal Q4 results, refreshed guidance for the Water Infrastructure segment, margin expansion in key operations, and a newly announced US$175 million equity offering that is earmarked...

In early March 2026, Marriott Vacations Worldwide appointed industry veteran Tony Walker as Executive Vice President and Chief Sales and Marketing Officer, while long-serving Executive Vice President and General Counsel James Hunter began transitioning toward retirement after nearly two decades with the company. These leadership moves come shortly after sizable non-cash impairment charges, a swing from net income of US$50 million to a net loss of US$431 million in the latest quarter, and...

In late February and early March 2026, Gilat Satellite Networks announced successful 3GPP-compliant 5G NTN connectivity over GEO satellites and secured multi-million dollar and US$39,000,000 orders for its in-flight connectivity hardware, while preparing to showcase a broad multi-orbit product portfolio at Satellite 2026. Together, these wins and technology milestones underline how Gilat is positioning its satellite and aviation solutions as core infrastructure for multi-orbit, 5G-aligned...

Tenet Healthcare recently presented at Barclays’ 28th Annual Global Healthcare Conference in Miami, while the broader healthcare sector reacted to February’s jobs report showing sizable job losses and concerns about weaker demand for medical services. This combination of company outreach to investors and sector-wide employment worries highlights how macroeconomic data can rapidly influence sentiment toward hospital operators like Tenet. We’ll now examine how sector-wide healthcare job losses...

EPR Properties recently entered into definitive agreements to acquire seven regional parks from Six Flags Entertainment for a gross transactional value of US$342 million, materially expanding its attractions portfolio across over 1,600 acres and 418 attractions in the U.S. and Canada. This is the company’s largest acquisition since 2017 and further tilts its portfolio toward experiential real estate, with long-term master leases to specialized park operators. Next, we’ll examine how this...

In early March 2026, Unstructured announced a partnership with Teradata to embed its data ingestion and processing platform natively into Teradata Enterprise Vector Store, enabling customers to convert documents, images, audio, and other unstructured content into AI-ready data inside Teradata’s governed environment across cloud and on-premises deployments. Teradata also introduced new agentic and multi-modal capabilities for Enterprise Vector Store, integrating hybrid search, multi-modal...

Recent enthusiasm around Maplebear (CART) has been driven by its latest quarterly results, growth in higher margin advertising, and a larger share repurchase authorization, including a US$250 million accelerated buyback that is now underway. See our latest analysis for Maplebear. The recent news has come alongside a 12.15% 1 month share price return, even though the 90 day share price return is a 15.98% decline and the 1 year total shareholder return is 1.41%. This suggests improving short...

Tidewater (TDW) has drawn fresh attention after reporting Q4 and full year 2025 results that showed much higher net income and earnings per share, along with higher 2026 revenue guidance between $1.43b and $1.48b. See our latest analysis for Tidewater. The earnings beat and higher 2026 revenue guidance appear to have fed into strong momentum, with a 30 day share price return of 22.08% and a 1 year total shareholder return of 100.74% suggesting growing investor confidence in Tidewater’s...

Elanco Animal Health reported past fourth quarter 2025 sales of US$1,144 million and full-year 2025 sales of US$4,715 million, alongside a net loss of US$276 million for the quarter and US$232 million for the year. Despite these losses, Elanco issued revenue guidance for 2026 of US$1,280 million to US$1,305 million for the first quarter and US$4,950 million to US$5,020 million for the full year, highlighting expected 4% to 6% growth that has underpinned continued analyst confidence in its...

In recent days, Comfort Systems USA reported a blockbuster quarter that delivered stronger earnings, cash flow, and new bookings across its operations. Analysts highlighted the company’s deep presence in data center projects and its experienced management team as key drivers of this performance. Next, we examine how this strong quarter and data center momentum may reshape Comfort Systems USA’s investment narrative for investors. Uncover the next big thing with 28 elite penny stocks that...

West Pharmaceutical Services (WST) is back in focus after fourth quarter 2025 results beat expectations and management issued upbeat 2026 guidance, highlighting GLP-1 exposure, cash generation, and shareholder return plans. See our latest analysis for West Pharmaceutical Services. At a share price of $248.06, West Pharmaceutical Services has seen short term share price pressure, with a 90 day share price return of a 6.77% decline and a year to date share price return of a 10.25% decline. Even...

Why Warby Parker Stock Is Back on Investors’ Radar Warby Parker (WRBY) is getting fresh attention after reporting full year 2025 results that returned the business to net profitability, issuing 2026 revenue guidance, and unveiling a US$100 million share repurchase program. See our latest analysis for Warby Parker. At a share price of US$25.28, Warby Parker has seen an 11.76% year to date share price return and a 24.65% total shareholder return over the past year. The 134.73% three year total...